Harper Hubbeling

7PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPacific Peoples mothers and babies health and wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.

Harper Hubbeling, Doris Leithner, Emily A Silverman

|Jun 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas.

Gustav Y Cederquist, Javin Schefflein, Sean M Devlin

|Oct 06, 2022
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers.

Harper Hubbeling, Noura Choudhury, Jessica Flynn

|Mar 09, 2021
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.

Jessica J Lin, Noura J Choudhury, Satoshi Yoda

|Jul 31, 2019
Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity.

Ibiayi Dagogo-Jack, Marguerite Rooney, Jessica J Lin

|May 23, 2018
Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.

Harper G Hubbeling, Shoshana M Rosenberg, Maria Cecilia González-Robledo

Pageof 2